Related Experiment Videos
Type 2 cytokine serum levels in healthy sickle cell disease patients
1Department of Pediatrics, Charles R. Drew University of Medicine and Science, King-Drew Medical Center, Los Angeles, California 90059, USA.
Insights
Children with sickle cell disease (SCD) show elevated levels of type 2 cytokines, including interleukin-4, -6, and -10. These cytokine increases may impair immune function, contributing to increased illness in SCD patients.
Area of Science:
- Immunology
- Hematology
- Pediatrics
Background:
- Sickle cell disease (SCD) is a hemoglobinopathy associated with significant morbidity and premature mortality.
- Children with SCD often display symptoms resembling immunodeficiency disorders.
Purpose of the Study:
- To investigate serum levels of type 2 cytokines (IL-4, IL-6, IL-10) in children with SCD compared to healthy controls.
- To explore the potential link between elevated cytokines and immune dysfunction in SCD.
Main Methods:
- Serum samples were collected from 56 children with SCD and 45 healthy controls.
- Concentrations of interleukin-4 (IL-4), IL-6, and IL-10 were measured using a standard curve (pg/mL).
Main Results:
- Significantly higher levels of IL-4 were found in SCD patients (13%) versus controls (2%).
- Increased IL-6 levels were observed in 78% of SCD patients compared to 41% of controls.
- Elevated IL-10 was detected in 41% of SCD patients versus 4% of controls.
Conclusions:
- Children with SCD exhibit higher circulating levels of type 2 cytokines IL-4, IL-6, and IL-10.
- These elevated cytokines may suppress humoral and cell-mediated immunity in SCD.
- This immune suppression could contribute to the increased morbidity seen in sickle cell disease.
Abstract:
Sickle cell disease (SCD) is characterized by significant morbidity and early mortality. Children with this hemoglobinopathy exhibit many of the manifestations associated with immunodeficiency disorders. Serum was obtained from 56 healthy SCD subjects and 45 normal healthy controls. Type 2 cytokines interleukin (IL)-4, IL-6, and IL-10 serum levels were measured. Concentrations were determined by reference to a standard curve, and results were expressed in pg/mL. Results revealed significant levels of IL-4 in 6 (13%) of 45 SCD patients compared with 1 (2%) of 45 controls. Increased levels of IL-6 were present in 35 (78%) of 45 SCD patients and 12 (41%) of 29 controls. Elevated levels of IL-10 were detectable in 13 (41%) of 42 SCD patients and 1 (4%) of 25 controls. High circulating levels of type 2 cytokines may suppress both humoral and cell-mediated immune functions in SCD, with resultant increased morbidity.